48 related articles for article (PubMed ID: 13747965)
1. [On the effect of carcinophylline and mitomycin C on the respiration and glycolysis of tumor cells].
SCHMIDT CG
Oncologia; 1960; 13():426-40. PubMed ID: 13747965
[No Abstract] [Full Text] [Related]
2. [On the inhibition of glycolysis of tumor cells by carcinophylline].
SCHMIDT CG
Klin Wochenschr; 1960 Apr; 38():334-5. PubMed ID: 14443021
[No Abstract] [Full Text] [Related]
3. [Dehydrogenase activity inhibition test in certain strains of human cancer cells in selecting antitumor antibiotics].
NAVASHIN SM; FOMINA IP; TERENT'EVA TG
Antibiotiki; 1960; 5():53-8. PubMed ID: 13728019
[No Abstract] [Full Text] [Related]
4. [Use of human tumor cell strains for the initial screening of antineoplastic antibiotics].
Talyzina VA; Timofeevskaia EA; Urazova AP; Firsova GA
Antibiotiki; 1965 Aug; 10(8):722-4. PubMed ID: 5887629
[No Abstract] [Full Text] [Related]
5. [Modification of carbohydrate metabolism of tumor cells by carcinophylline].
SCHMIDT CG
Z Krebsforsch; 1961; 64():328-34. PubMed ID: 14498695
[No Abstract] [Full Text] [Related]
6. Reevaluation of a screening program for antineoplastic agents.
Sloboda AE
Cancer Res; 1966 Jul; 26(7 Pt 2):753-60. PubMed ID: 5212553
[No Abstract] [Full Text] [Related]
7. Energy deregulation: licensing tumors to grow.
Garber K
Science; 2006 May; 312(5777):1158-9. PubMed ID: 16728625
[No Abstract] [Full Text] [Related]
8. Methyl mitomycin.
WAGNER AF; GITTERMAN CO
Antibiot Chemother (Northfield); 1962 Jul; 12():464-8. PubMed ID: 14004326
[No Abstract] [Full Text] [Related]
9. [Interference with the activity of some dehydrogenases in intact cells of Ehrlich ascites carcinoma (EAC) as 1 of the criteria in the investigation of carcinostatic antibiotics and other drugs].
DROBNICA L
Neoplasma; 1960; 7():385-91. PubMed ID: 13724433
[No Abstract] [Full Text] [Related]
10. Effect of mitomycin C on interactions between temperate phages and bacteria.
LEVINE M
Virology; 1961 Apr; 13():493-9. PubMed ID: 13761490
[No Abstract] [Full Text] [Related]
11. Effect of sarcolysin peptides on the metabolism of purine nucleotides in tumor cells.
ROMANOVA IN
Biokhimiia; 1961; 26():381-7. PubMed ID: 14038750
[No Abstract] [Full Text] [Related]
12. Mithramycin inhibition of ribonucleic acid synthesis.
Yarbro JW; Kennedy BJ; Barnum CP
Cancer Res; 1966 Jan; 26(1):36-9. PubMed ID: 5901746
[No Abstract] [Full Text] [Related]
13. Metal complexes of natural melophlins and their cytotoxic and antibiotic activities.
Biersack B; Diestel R; Jagusch C; Sasse F; Schobert R
J Inorg Biochem; 2009 Jan; 103(1):72-6. PubMed ID: 18951635
[TBL] [Abstract][Full Text] [Related]
14. 2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization.
Ahrar K; Newman RA; Pang J; Vijjeswarapu MK; Wallace MJ; Wright KC
J Vasc Interv Radiol; 2004 Sep; 15(9):901-5. PubMed ID: 15361556
[TBL] [Abstract][Full Text] [Related]
15. [Certain aspects of the study of neocid].
DERKACH VS
Antibiotiki; 1960; 5():34-40. PubMed ID: 13722048
[No Abstract] [Full Text] [Related]
16. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).
Tanaka T; Shiramoto S; Miyashita M; Fujishima Y; Kaneo Y
Int J Pharm; 2004 Jun; 277(1-2):39-61. PubMed ID: 15158968
[TBL] [Abstract][Full Text] [Related]
17. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
[TBL] [Abstract][Full Text] [Related]
18. Antineoplastic and cytogenetic effects of chlorpromazine on human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.
Lialiaris TS; Papachristou F; Mourelatos C; Simopoulou M
Anticancer Drugs; 2009 Sep; 20(8):746-51. PubMed ID: 19584706
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of an antibiotic peptide derived from apoprotein E.
Kojima T; Fujimitsu Y; Kojima H
In Vivo; 2005; 19(1):261-4. PubMed ID: 15796184
[TBL] [Abstract][Full Text] [Related]
20. Targeting mitochondria emerges as therapeutic strategy.
Garber K
J Natl Cancer Inst; 2005 Dec; 97(24):1800-1. PubMed ID: 16368937
[No Abstract] [Full Text] [Related]
[Next] [New Search]
